Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter / Nine Months ended December 31, 2018, on Tuesday, February 12, 2019 at 04.30 P.M. local time. Mr. A. Sundararaju, CFO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Miss. Amruta Velumani, Director, Mr. Sachin Salvi, Vice-President- Finance, and Dr. Caesar Sengupta, Vice President- Operations, will represent the Company. Dial-in details are given in the copy of enclosed Invite of M/s. Prabhudas Lilladher, who are organizing the con-call.
11-02-2019
Bigul

Thyrocare net slides to Rs 20.15 cr in Q3

 Thyrocare Technologies Saturday said its consolidated net profit slipped slightly to Rs 20.15 crore in the third quarter ended December 31. The compa
09-02-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Outcome of Board Meeting

 This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the Quarter / Nine Month Period ended December 31, 2018. The Stand-alone and Consolidated unaudited financial results for the Quarter / Nine Month Period ended December 31, 2018, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform that the meeting commenced at 17.30 hours and ended at 19.45 hours today, the 9th February 2019.
09-02-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Dr. A. Velumani, Chairman, Managing Director & CEO, would be participating at '10th Eureka Conference- London' organized by M/s. Motilal Oswal Financial Services Limited, at St James Court, A Taj Hotel, London on 11th and 12th February 2019, where representatives of various fund houses would be meeting him.
07-02-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Dr. A. Velumani, Chairman & Managing Director, would be participating at '10th Enterprising India Investors' Conference organized by M/s. IIFL- Institutional Equities, at Hotel Trident BKC, Mumbai, on Wednesday, 13th February 2019, where representatives of various fund houses would be meeting him, from 02.00 P.M to 6.00 P.M. Please note that there could be last minute change in the conference timings and some of our executives might accompany him.
31-01-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sachin Salvi, General Manager- Finance would be participating at 'Build India, New India' Investor Conference organized by M/s. Antique Stock Broking Limited, at Hotel Sofitel BKC, Mumbai, on Tuesday, 12th February 2019, where representatives of various fund houses would be meeting him, from 10.00 A.M to 2.00 P.M. Please note that there could be last minute change in the conference timings and some of our other executives might accompany him.
31-01-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

 We have intimated to you by a separate letter about the meeting of the Board of Directors scheduled to be held on Saturday, February 09, 2019, to consider and approve unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter / nine months ended December 31, 2018 and declaration of interim dividend, if any. In this regard, we would like to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, from January 29, 2019 to February 12, 2019 (both days inclusive).
28-01-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Inter Alia, To Consider And Approve Unaudited Stand-Alone And Consolidated Financial Results Of The Company For The Quarter / Nine Months Ended December 31, 2018, And Declaration Of Interim Dividend, If Any.

 Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2019 ,inter alia, to consider and approve 1. Unaudited financial results - both Stand-alone and Consolidated - for the quarter / nine months ended December 31, 2018. 2. Decide on declaration of interim dividend, if any.
28-01-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ramjee DoraiDesignation :- Company Secretary and Compliance Officer
10-01-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholding for the Period Ended December 31, 2018

 Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
10-01-2019
Next Page
Close

Let's Open Free Demat Account